Speakers

Overseas Invited Speakers

HSANZ

Professor Alan K. Burnett Cardiff University School of Medicine, UK
	Alan K. Burnett was appointed chair and head of the Department of Haematology at the University of Wales College of Medicine (now Cardiff University) in 1992. In 2002, the National Cancer Research Institute was established in the UK and Professor Burnett was appointed as chair of the National Cancer Research Institute Haematological Oncology Study Group. He was appointed chair of the Medical Research Council Adult Leukaemia Working Party in 1989 and has acted as a coordinator of the MRC -10, -11, -12, -14, -15, -16, and -17 trials. Professor Burnett's main research interest is the development of treatments for acute myeloid leukemia. He has served on numerous advisory committees and is past president of the British Society of Haematology and chair of the UK National Training Program. He was elected as a Fellow of the Academy of Medical Science in 2002 and was awarded the Gold Medal of the British Society for Haematology in 2004, and was appointed as an MBE in the Queen's Birthday Honours for services to medicine in 2008.
Professor Martin Dreyling University Hospital Grossharden, Ludwig Maximilians-University, Munich, Germany
	Martin Dreyling is Professor of Medicine and head of the lymphoma programme in the Department of Medicine III, University Hospital Gro?hadern, Ludwig Maximilians-University, Munich. He studied at the Universities of Düsseldorf, Giessen, Tübingen and Würzburg, and completed his clinical training at the Universities of Bonn, Münster, Göttingen and Munich. In addition, he was visiting scientist at the University of Chicago 1992-1995. Dr Dreyling's scientific focus is on the molecular basis of malignant transformation and factors of susceptibility in lymphomagenesis, cell cycle disregulation in mantle cell lymphoma (MCL) and secondary genetic alterations and biological prognostic factors in malignant lymphoma. He is also interested in innovative therapeutic approaches to indolent lymphoma, including radioactively labelled antibodies and non-myeloablative allogeneic transplantation. Dr Dreyling is Coordinator of the European MCL Network and Assistant Coordinator of the German Low Grade Lymphoma Study Group. He has co-authored more than 300 scientific papers and abstracts in international peer-reviewed journals.
Professor Thierry Facon, France
	Thierry Facon is Professor of Hematology in the Department of Hematology, Lille University Hospital, France, a position he has held since 2000. Professor Facon attained his MD at Lille University School of Medicine in 1987 and he became Assistant Professor of Hematology at Lille University Hospital in 1989. Between 2003 and 2006, Professor Facon was President of the French-speaking Myeloma Group (Intergroupe Francophone du Myélome [IFM]) and in 2005 he was appointed Vice President of the French Society of Hematology. Professor Facon has presented at several international congresses including ASCO 2006 plenary session. The author and co-author of a number of articles, his work has been published in various prestigious international journals such as the Lancet, New England Journal of Medicine and Blood.
Professor Sergio Giralt, MD Anderson Cancer Center, USA
	Sergio Giralt, Professor of Medicine, joined the University of Texas MD Anderson Cancer Center, Department of Stem Cell Transplantation and Cellular Therapy as a Medical Oncology/Hematology Fellow in 1989. Among numerous administrative responsibilities, he is the Deputy Chair of the Department. Dr Giralt became involved with the International Bone Marrow Registry in 1992 and as a fellow proposed a study looking at the effects of interferon on transplant outcomes in Chronic Myelogenous Leukemia. Since that time, he has been heavily involved in many CIBMTR activities. He has chaired multiple sessions in the Tandem Meetings and has been an active participant in the nursing, data management and pharmacist symposiums. He is the Chair of the Center for International Blood and Marrow Transplant Research (CIBMTR). Dr Giralt's interests include minitransplant for acute leukemia and transplant for myeloma. He is a current member of the American College of Physicians, American Society of Hematology, American Society of Clinical Oncology, North American Society of Blood and Marrow Transplantation, International Society of Hematotherapy and Graft Engineering, and International Society of Haematology.
Prof Radek Skoda University Hospital Basel, Switzerland
	Prof Radek Skoda is the Professor of Molecular Medicine and Chairs the Department of Research at the University Hospital Basel as well as the Department of Biomedicine, University of Basel, Switzerland. He has previously worked in Harvard Medical School and the German Cancer Research Centre. Prof Skoda was honoured with the 2007 American Society of Hematology Ham-Wasserman Lecture Award, speaking on his pioneering contributions to the molecular pathogenesis of myeloproliferative disorders, particularly the characterisation of c-mpl and the mutated form of JAK2..
Dr Daniel G Tenen Harvard Institute of Medicine, USA
	Daniel G Tenen is Professor of Medicine at Harvard Medical School, as well as Director of the Blood Program of the Harvard Stem Cell Institute, Director of the Cancer Biology Program at Beth Israel Deaconess Medical School, co-Director of the Harvard Medical School Hematology Training Grant, and Distinguished Visiting Professor at the National University of Singapore. His research efforts have focused on transcription factors, gene regulation, and their role in normal differentiation and cancer. His research contributions have included establishing the role of transcription factors in differentiation of myeloid cells and the role of disruption of these pathways in leukemia and lung cancer. He completed training in Internal Medicine at Brigham & Women's Hospital and Medical Oncology at Dana Farber Cancer Institute, and his research training as a postdoctoral fellow in David Livingston’s laboratory at Dana Farber Cancer Institute. He established his own independent laboratory at Beth Israel Deaconess Medical School, Harvard Medical School, in 1984.
Dr Neal Young National Heart, Lung and Blood Institute, NIH, USA
	Neal S Young is Chief of the Hematology Branch of the National Heart, Lung and Blood Institute and Director of the new NIH Center for Human Immunology, Autoimmunity, and Inflammation. Following internal medicine residency at Massachusetts General Hospital, Dr. Young came first to the National Institutes of Health to learn protein biochemistry in the laboratory of Nobel Prize winner Christian Anfinsen. After a fellowship in hematology at Barnes Hospital of Washington University in St. Louis, Dr Young returned to NHLBI for a second post-doctoral fellowship in molecular biology under Dr. Arthur Nienhuis. He developed an interest in aplastic anemia during this time and established an independent section in the former Clinical Hematology Branch to study human bone marrow failure, both its treatment and pathogenesis. The clinic of the Branch is perhaps the major referral center for bone marrow failure syndromes in the world. Accomplishments from Dr Young's laboratory have included the successful development of immunosuppressive therapies for patients with aplastic anemia and related syndromes; the description of B19 parvovirus as an agent of human disease, including development of a vaccine now in clinical trials; the elucidation of both the immunology and genetics of acquired aplastic anemia, including the recent first demonstration of pathogenic mutations in TERT, the gene for the telomerase enzyme. Dr Young is co-discoverer on seven patents relating to parvoviruses and also the detection of mutations in human single hematopoietic cells.

Professor Lena Napolitano University of Michigan Health Systems, USA
	Lena Napolitano is Professor of Surgery at the University of Michigan School of Medicine, Chief of Surgical Critical Care and Associate Chair for Critical Care for the Department of Surgery. She is a Fellow of the American College of Surgeons, American College of Critical Care Medicine, and the American College of Chest Physicians. Dr Napolitano is a member and holds leadership positions in numerous professional organizations in surgery, trauma and surgical critical care. Dr Napolitano has a research effort in trauma and surgical critical care, and is Principal Investigator on a number of research grants focused on translational research. She is a member of the Editorial Boards of the journals Surgical Infections, Journal of Surgical Research and New Surgery, Molecular Basis of Surgical Disease and New Technology. Dr Napolitano has received such honors as the 2002 Association of Women Surgeons Distinguished Member Award, awarded to a member that exemplifies the ideals and mission of the association. Her other honors include Surgical Critical Care Educator of the Year Award in 1998, 1999, and 2000 from the University of Maryland Medical Systems, and the Surgery Teacher of the Year Award in 1999 and 2001. She has been a mentor to a number of research fellows at the surgical resident and fellow level. Her research group that she mentors has received numerous awards, including the annual Resident Paper Competition of the American College of Surgeons Committee on Trauma, Society of Critical Care Medicine Best Paper award, and numerous others.
Paul M. Ness, M.D. Johns Hopkins Medical Institutions, USA
	Dr. Ness is director of the Transfusion Medicine Division at The Johns Hopkins Hospital and professor of Pathology, Medicine, and Oncology at The Johns Hopkins University School of Medicine in Baltimore, Maryland. He received his undergraduate education at the Massachusetts Institute of Technology and his M.D. degree from the State University of New York at Buffalo. His postgraduate work includes residency in internal medicine at Johns Hopkins, fellowship training in hematology-oncology at the University of California San Francisco, and transfusion medicine fellowship at Irwin Memorial Blood Bank in San Francisco. From 1972-1974, Dr. Ness was a staff associate in the Division of Blood Diseases and Resources of the National Heart, Lung, and Blood Institute at the National Institutes of Health in Bethesda, Maryland. Dr. Ness has been a member of the AABB Board of Directors for many years and became President in 1999. He served on the editorial boards of Transfusion and AABB Press and became editor of Transfusion in July, 2003. Dr. Ness has written over 150 articles for medical journals and has reviewed manuscripts for many journals. He is a co-editor of two comprehensive texts in transfusion medicine, The Scientific Basis of Transfusion Medicine and Blood Banking and Transfusion Medicine, Basic Principles and Practice. Dr. Ness also has extensive experience in transfusion related research with emphasis upon transfusion related complications. He serves as PI for the Johns Hopkins site of the Transfusion Medicine Hemostasis Clinical Trial Network, funded by NHLBI. Dr. Ness is the co-PI for a project funded by the REDS II program to study donor virus epidemiology issues in China.
Professor Martin L Olsson The Regional Blood Center, Lund University Hospital, Sweden
	Martin Olsson is a Professor of Transfusion Medicine at Lund University, Lund, Sweden and a Visiting Associate Professor/Lecturer at Harvard Medical School, Boston, MA, USA. He received his medical degree and PhD at Lund University. His main clinical and research interests are in the molecular genetics of red cell surface markers with a special emphasis on carbohydrate histo-blood group systems and blood typing. His scientific contributions have focused on clarifying the correlation between red cell phenotypes and the underlying genetic polymorphisms, as well as glycosyltransferase function in different blood groups. He is also interested in pathogen-related aspects of blood group antigens and different mechanisms of protection against hemolysis, including exoglycosidase-treated red cells for ABO-universal transfusion. Dr. Olsson serves as Associate Editor of Transfusion Medicine and is a member of the Editorial Board of Transfusion. His awards include the Jean Julliard Prize from the International Society of Blood Transfusion, the Race and Sanger Award from the British Blood Transfusion Society, the Fernström Prize at Lund University and the Hain Foundation Prize.
A/ Professor Benny Sorenson UK
	Benny Sørensen is a MD, Ph.D., and Associate Professor. He was educated in Professor Jørgen Ingerslevs Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Skejby, Denmark. His primary research areas are patients with congenital and acquired bleeding disorders and the recording of rate specific characteristics of whole blood clot formation in order to individually tailor haemostatic intervention. Special interests include patients suffering from severe haemophilia A and inhibitors as well as management of peri-operative bleeding. August 2008 he was appointed a Senior Clinical Research Fellow and Honorary Lecturer at the Centre for Haemophilia and Thrombosis at Guy's and St Thomas NHS Foundation Trust and King's College London School of Medicine, London, UK; working as a co-ordinator and facilitator of a new Haemostasis Research Unit. Since 2003, Dr Sørensen has published and presented more than 60 original scientific publications. He is a board member and scientific secretary of the Danish Society of Thrombosis and Haemostasis, and an invited reviewer for a number of international scientific journals, and part of the editorial advisory board of Journal of Thrombosis and Haemostasis.
Dr Dafydd Thomas Wales
	Dafydd Thomas works as an Anaesthetist in Intensive Care Medicine in Swansea. He has been involved in postgraduate education since his appointment in 1989. First as college tutor, then deputy regional and regional advisor for Wales for the Royal College of Anaesthetists. He recently completed a period as an examiner for the RCA starting as a primary examiner in 1999 and finishing as a final examiner during the last academic year. During this time he has organised the South Wales Anaesthetic Course and the Morriston Critical Care Refresher. He is a regular lecturer on courses organised by both the Royal College of Anaesthetists and the Association of Anaesthetists of Great Britain and Ireland. A busy and well traveled lecturer he has lately been seconded on a part time basis to the Welsh Blood Service to continue this work advocating and promoting appropriate use of blood components. He is currently President Elect of the BBTS (British Blood Transfusion Society), on the Board of Directors of NATA (International Network for the Advancement of Transfusion Alternatives), and chairs a working Party on cell salvage for the ISBT (International Society of Blood Transfusion). He is an ex council member of BBTS, is chair of the Blood Implementation Group (Welsh Assembly Government) a member of the Clinical Advisory Group and Blood Policy Group (WAG), He is currently involved in further UK guideline formulation on intra- and postoperative cell salvage and a member of the UK Cell Salvage Action Group.

Professor Marco Cattaneo Ospedale San Paolo, University of Milan, Italy
	Professor Cattaneo is currently the Professor of Internal Medicine and the Director of the Hematology and Thrombosis Unit at the University of Milan, Italy. Since graduating from the same University in 1975, he developed a strong research record in haemostasis and thrombosis, with over 180 published peer-reviewed articles, and is the member of the editorial board of a number of prominent international journals. Current areas of research interest include the pathophysiology of primary hemostasis including the role platelet P2 receptors, the use of point of care devices to evaluate both anti-platelet therapy and bleeding disorders, and aspirin resistance.
Dr Nigel Key University of North Carolina at Chapel Hill School of Medicine, USA
	Dr Nigel Key is the Harold R Roberts Professor of Medicine at the University of North Carolina at Chapel Hill, USA. He is also Chief of the Hematology Section and Director of the Harold R Roberts Comprehensive Hemophilia Diagnostic and Treatment Center at UNC. Dr Key is a graduate of the Universities of St Andrew's and Manchester in the UK. He is currently President of the Hemophilia and Thrombosis Research Society of North America, a member of the Executive Committee of the World Federation of Hemophilia, and a Council member of the International Society of Thrombosis and Hemostasis.
Professor Paul Kyrle AKH-Wien/Universitatskliniken, Austria
	Paul Kyrle is Associate Professor of Medicine at the University Hospital in Vienna, Austria. He also serves as the Head of the Karl Landsteiner-Institute of Clinical Thrombosis Research in Vienna, Austria. He graduated from medical school in Vienna, Austria, and received his scientific training in Vienna, London (Royal College of Surgeons), La Jolla (Scripps Research Institute) and New York (Mount Sinai Medical Center). His scientific work is currently focused on elucidating the mechanisms leading to (recurrent) venous thrombosis and pulmonary embolism. He is the principal investigator of AUREC, one of the largest studies to investigate predictors and risk factors of recurrent venous disease. Paul Kyrle is the author of more than 150 articles in peer-reviewed journals and served as Congress President on the occasion of the 54th Annual Meeting of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH). He is also member of the German Academy of Sciences Leopoldina.

Ms Sherri Ozawa USA

Sherri Ozawa, RN, has been involved in the field of patient blood management for more fifteen years. She serves as the Director of The Institute for Patient Blood Management at Englewood Hospital and Medical Center. Her background in critical care nursing enabled her to help create one of the largest multidisciplinary bloodless medicine and surgery programs in the world. She has lectured throughout the United States and internationally, with a particular focus on the nursing aspects of blood management. She has published numerous articles on the subject, and continues to be actively involved in research in the field of blood conservation, transfusion outcomes, and the economics of transfusion.